AK, G. Et Al. 2017. Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin. BMC CANCER , vol.17 .

AK, G., Tada, Y., Shimada, H., METİNTAŞ, S., Ito, M., Hiroshima, K., ... Tagawa, M.(2017). Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin. BMC CANCER , vol.17.

AK, GÜNTÜLÜ Et Al. "Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin," BMC CANCER , vol.17, 2017

AK, GÜNTÜLÜ Et Al. "Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin." BMC CANCER , vol.17, 2017

AK, G. Et Al. (2017) . "Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin." BMC CANCER , vol.17.

@article{article, author={GÜNTÜLÜ AK Et Al. }, title={Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin}, journal={BMC CANCER}, year=2017}